Otomandibular syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141136
Who is this for?
Show terms as
10Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Otomandibular syndrome, also known as otomandibular dysostosis, is a rare congenital condition characterized by malformations affecting the ears and the mandible (lower jaw). This condition falls within the spectrum of craniofacial anomalies involving structures derived from the first and second branchial arches. Key clinical features include microtia or anotia (underdevelopment or absence of the external ear), conductive hearing loss, mandibular hypoplasia (underdevelopment of the lower jaw), and facial asymmetry. Additional features may include preauricular tags, middle ear anomalies, and temporomandibular joint abnormalities. The severity of the condition can vary considerably between affected individuals. The body systems primarily affected are the craniofacial skeleton, the external and middle ear structures, and the associated soft tissues of the face. Some patients may also present with associated anomalies such as lateral facial clefts or other branchial arch-derived structural defects. The condition is typically apparent at birth due to the visible craniofacial malformations. Treatment is symptomatic and supportive, focusing on the specific manifestations present in each individual. Management often involves a multidisciplinary team including craniofacial surgeons, otolaryngologists, audiologists, and orthodontists. Surgical reconstruction of the mandible and external ear may be performed to improve function and appearance. Hearing aids or bone-anchored hearing devices may be used to address conductive hearing loss. Early audiological assessment is important to support speech and language development. There is currently no cure for the underlying condition.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Otomandibular syndrome.

View clinical trials →

No actively recruiting trials found for Otomandibular syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Otomandibular syndrome community →

Specialists

10 foundView all specialists →
MP
Matthew L Speltz, PhD
SEATTLE, WA
Specialist
PI on 1 active trial
CM
Carrie L Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
BB
Barbara B Biesecker
CLARKS SUMMIT, PA
Specialist
PI on 16 active trials
MP
Mark Sun, PhD
COON RAPIDS, MN
Specialist
PI on 1 active trial
YM
yasser el hadidi, mds
Specialist
PI on 1 active trial
CD
Caroline ROORYCK THAMBO, Dr
Specialist
PI on 1 active trial
CM
Carrie Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
DM
Daniela Y Tanikawa, MD
Specialist
PI on 1 active trial
AP
Azra Mehmood, PhD
Specialist
PI on 1 active trial
SP
Sheikh Riazuddin, PhD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Otomandibular syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Otomandibular syndromeForum →

No community posts yet. Be the first to share your experience with Otomandibular syndrome.

Start the conversation →

Latest news about Otomandibular syndrome

No recent news articles for Otomandibular syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Otomandibular syndrome

What is Otomandibular syndrome?

Otomandibular syndrome, also known as otomandibular dysostosis, is a rare congenital condition characterized by malformations affecting the ears and the mandible (lower jaw). This condition falls within the spectrum of craniofacial anomalies involving structures derived from the first and second branchial arches. Key clinical features include microtia or anotia (underdevelopment or absence of the external ear), conductive hearing loss, mandibular hypoplasia (underdevelopment of the lower jaw), and facial asymmetry. Additional features may include preauricular tags, middle ear anomalies, and te

How is Otomandibular syndrome inherited?

Otomandibular syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Otomandibular syndrome typically begin?

Typical onset of Otomandibular syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Otomandibular syndrome?

10 specialists and care centers treating Otomandibular syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.